Clinical outcome of HIV viraemic controllers and noncontrollers with normal CD4 counts is exclusively determined by antigen-specific CD8+ T-cell-mediated HIV suppression

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Tansiri, Yada ^a   Rowland Jones, Sarah L ^b   Ananworanich, Jintanat ^c,d   Hansasuta, Pokrath ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d US Military HIV Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; HLA B ANTIGEN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INFECTION CONTROL; INTERFERON PRODUCTION; MAJOR CLINICAL STUDY; MALE; T LYMPHOCYTE ACTIVATION; VIRUS ISOLATION; CELL CULTURE; CROSS-SECTIONAL STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MIDDLE AGED; THAILAND; VIREMIA; VIROLOGY; YOUNG ADULT;

ADULT; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CROSS-SECTIONAL STUDIES; FEMALE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; THAILAND; VIREMIA; YOUNG ADULT;

EID: 84929996511     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118871     Document Type: Article

References (45)

1. Coffin J, Haase A, Levy JA, Montagnier L, Oroszlan S, Teich N, et al. Human immunodeficiency viruses. Science. 1986; 232: 697. PMID: 3008335
2. Poropatich K, Sullivan DJ Jr. Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression. J Gen Virol. 2011; 92: 247-268. doi: 10.1099/vir.0.027102-0 PMID: 21106806
3. Okulicz JF, Marconi VC, Landrum ML, Wegner S, Weintrob A, Ganesan A, et al. Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J Infect Dis. 2009; 200: 1714-1723. doi: 10.1086/646609 PMID: 19852669
4. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature. 1987; 328: 345-348. PMID: 3496541
5. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999; 283: 857-860. PMID: 9933172
6. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med. 1999; 189: 991-998. PMID: 10075982
7. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med. 2007; 13: 46-53. PMID: 17173051
8. Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, Casazza JP, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol. 2001; 75: 11983-11991. PMID: 11711588
9. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D, et al. Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load. Journal of Virology. 2003; 77: 2081-2092. PMID: 12525643
10. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006; 107: 4781-4789. PMID: 16467198
11. Techakriengkrai N, Tansiri Y, Hansasuta P Poor HIV control in HLA-B∗27 and B.∗57/58 noncontrollers is associated with limited number of polyfunctional Gag p24-specific CD8+ T cells. AIDS. 2013; 27: 17-27. doi: 10.1097/QAD.0b013e32835ac0e1 PMID: 23079801
12. Owen RE, Heitman JW, Hirschkorn DF, Lanteri MC, Biswas HH, Martin JN, et al. HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS. 2010; 24: 1095-1105. doi: 10.1097/QAD.0b013e3283377a1e PMID: 20400885
13. Almeida JR, Sauce D, Price DA, Papagno L, Shin SY, Moris A, et al. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood. 2009; 113: 6351-6360. doi: 10.1182/blood-2009-02-206557 PMID: 19389882
14. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, Bornstein E, et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med. 2007; 204: 2473-2485. PMID: 17893201
15. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol. 2002; 3: 1061-1068. PMID: 12368910
16. Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, Weeks KA, et al. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity. 2008; 29: 1009-1021. doi: 10.1016/j.immuni.2008.10.010 PMID: 19062316
17. Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, Shin LY, et al. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog. 2010; 6: e1000917. doi: 10.1371/journal.ppat.1000917 PMID: 20523897
18. Dong T, Stewart-Jones G, Chen N, Easterbrook P, Xu X, Papagno L, et al. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med. 2004; 200: 1547-1557. PMID: 15596521
19. Chen H, Ndhlovu ZM, Liu D, Porter LC, Fang JW, Darko S, et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat Immunol. 2012; 13: 691-700. doi: 10.1038/ ni.2342 PMID: 22683743
20. Saez-Cirion A, Lacabaratz C, Lambotte O, Versmisse P, Urrutia A, Boufassa F, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci U S A. 2007; 104: 6776-6781. PMID: 17428922
21. Saez-Cirion A, Sinet M, Shin SY, Urrutia A, Versmisse P, Lacabaratz C, et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J Immunol. 2009; 182: 7828-7837. doi: 10.4049/jimmunol.0803928 PMID: 19494307
22. Streeck H, Frahm N, Walker BD The role of IFN-gamma Elispot assay in HIV vaccine research. Nat Protoc. 2009; 4: 461-469. doi: 10.1038/nprot.2009.7 PMID: 19282851
23. Lamoreaux L, Roederer M, Koup R Intracellular cytokine optimization and standard operating procedure. Nat Protoc. 2006; 1: 1507-1516. PMID: 17406442
24. van 't Wout AB, Schuitemaker H, Kootstra NA Isolation and propagation of HIV-1 on peripheral blood mononuclear cells. Nat Protoc. 2008; 3: 363-370. doi: 10.1038/nprot.2008.3 PMID: 18323807
25. Saez-Cirion A, Shin SY, Versmisse P, Barre-Sinoussi F, Pancino G Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses. Nat Protoc. 2010; 5: 1033-1041. doi: 10. 1038/nprot.2010.73 PMID: 20539279
26. Goulder PJ, Watkins DI Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol. 2008; 8: 619-630. doi: 10.1038/nri2357 PMID: 18617886
27. Berger CT, Frahm N, Price DA, Mothe B, Ghebremichael M, Hartman KL, et al. High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control. J Virol. 2011; 85: 9334-9345. doi: 10.1128/JVI.00460-11 PMID: 21752903
28. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med. 1996; 2: 405-411. PMID: 8597949
29. International HIVCS, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010; 330: 1551-1557. doi: 10.1126/science.1195271 PMID: 21051598
30. Zhang Y, Peng Y, Yan H, Xu K, Saito M, Wu H, et al. Multilayered defense in HLA-B51-associated HIV viral control. J Immunol. 2011; 187: 684-691. doi: 10.4049/jimmunol.1100316 PMID: 21670313
31. Sriwanthana B, Hodge T, Mastro TD, Dezzutti CS, Bond K, Stephens HA, et al. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand. AIDS Res Hum Retroviruses. 2001; 17: 719-734. PMID: 11429112
32. Fogg MH, Wirth LJ, Posner M, Wang F Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma. Proc Natl Acad Sci U S A. 2009; 106: 3318-3323. doi: 10.1073/pnas.0813320106 PMID: 19211798
33. Comoli P, Pedrazzoli P, Maccario R, Basso S, Carminati O, Labirio M, et al. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes. J Clin Oncol. 2005; 23: 8942-8949. PMID: 16204009
34. Luo XH, Huang XJ, Liu KY, Xu LP, Liu DH Protective immunity transferred by infusion of cytomegalovirus- specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2010; 16: 994-1004. doi: 10.1016/j.bbmt.2010.02.007 PMID: 20167279
35. Kottilil S, Gamberg J, Bowmer I, Trahey J, Howley C, Gallant M, et al. Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells. J Clin Immunol. 2000; 20: 175-186. PMID: 10941825
36. Buzon MJ, Massanella M, Llibre JM, Esteve A, Dahl V, Puertas MC, et al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med. 2010; 16: 460-465. doi: 10.1038/nm.2111 PMID: 20228817
37. Rolland M, Heckerman D, Deng W, Rousseau CM, Coovadia H, Bishop K, et al. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One. 2008; 3: e1424. doi: 10. 1371/journal.pone.0001424 PMID: 18183304
38. Julg B, Williams KL, Reddy S, Bishop K, Qi Y, Carrington M, et al. Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses. J Virol. 2010; 84: 5540-5549. doi: 10.1128/JVI. 02031-09 PMID: 20335261
39. Schneidewind A, Brockman MA, Sidney J, Wang YE, Chen H, Suscovich TJ, et al. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J Virol. 2008; 82: 5594-5605. doi: 10. 1128/JVI.02356-07 PMID: 18385228
40. Draenert R, Verrill CL, Tang Y, Allen TM, Wurcel AG, Boczanowski M, et al. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J Virol. 2004; 78: 630-641. PMID: 14694094
41. Lecuroux C, Girault I, Cheret A, Versmisse P, Nembot G, Meyer L, et al. CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection. PLoS One. 2013; 8: e59767. doi: 10.1371/journal.pone.0059767 PMID: 23555774
42. Yang H, Wu H, Hancock G, Clutton G, Sande N, Xu X, et al. Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection. J Infect Dis. 2012; 206: 552-561. doi: 10. 1093/infdis/jis379 PMID: 22711904
43. Spentzou A, Bergin P, Gill D, Cheeseman H, Ashraf A, Kaltsidis H, et al. Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates. J Infect Dis. 2010; 201: 720-729. doi: 10.1086/650492 PMID: 20132004
44. Schneidewind A, Brockman MA, Yang R, Adam RI, Li B, Le Gall S, et al. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol. 2007; 81: 12382-12393. PMID: 17804494
45. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-1. Science. 2007; 317: 944-947. PMID: 17641165